WO2003016279A1 - Composes polycycliques fusionnes - Google Patents
Composes polycycliques fusionnes Download PDFInfo
- Publication number
- WO2003016279A1 WO2003016279A1 PCT/JP2002/007783 JP0207783W WO03016279A1 WO 2003016279 A1 WO2003016279 A1 WO 2003016279A1 JP 0207783 W JP0207783 W JP 0207783W WO 03016279 A1 WO03016279 A1 WO 03016279A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- general formula
- benzene ring
- group represented
- fused
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002455298A CA2455298C (en) | 2001-08-09 | 2002-07-31 | Condensed polycyclic compounds |
EP02758780A EP1424326B1 (en) | 2001-08-09 | 2002-07-31 | Fused-polycyclic compounds |
KR1020047002009A KR100622879B1 (ko) | 2001-08-09 | 2002-07-31 | 축합 다환식 화합물 |
DE60226878T DE60226878D1 (de) | 2001-08-09 | 2002-07-31 | Kondensierte polycyclische verbindungen |
MXPA04001171A MXPA04001171A (es) | 2001-08-09 | 2002-07-31 | Compuestos policiclicos condensados. |
US10/486,088 US7153859B2 (en) | 2001-08-09 | 2002-07-31 | Condensed polycyclic compounds |
AU2002325493A AU2002325493B2 (en) | 2001-08-09 | 2002-07-31 | Condensed Polycyclic Compounds |
HK04107642.3A HK1064673A1 (en) | 2001-08-09 | 2004-10-05 | Fused-polycyclic compounds |
US11/515,907 US7550475B2 (en) | 2001-08-09 | 2006-09-06 | Condensed polycyclic compounds |
US11/515,737 US7550464B2 (en) | 2001-08-09 | 2006-09-06 | Condensed polycyclic compounds |
US11/515,928 US7550476B2 (en) | 2001-08-09 | 2006-09-06 | Condensed polycyclic compounds |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001241521 | 2001-08-09 | ||
JP2001241517 | 2001-08-09 | ||
JP2001-241521 | 2001-08-09 | ||
JP2001-241502 | 2001-08-09 | ||
JP2001-241517 | 2001-08-09 | ||
JP2001241502 | 2001-08-09 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10486088 A-371-Of-International | 2002-07-31 | ||
US11/515,928 Division US7550476B2 (en) | 2001-08-09 | 2006-09-06 | Condensed polycyclic compounds |
US11/515,907 Division US7550475B2 (en) | 2001-08-09 | 2006-09-06 | Condensed polycyclic compounds |
US11/515,737 Division US7550464B2 (en) | 2001-08-09 | 2006-09-06 | Condensed polycyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003016279A1 true WO2003016279A1 (fr) | 2003-02-27 |
Family
ID=27347300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/007783 WO2003016279A1 (fr) | 2001-08-09 | 2002-07-31 | Composes polycycliques fusionnes |
Country Status (15)
Country | Link |
---|---|
US (4) | US7153859B2 (ja) |
EP (1) | EP1424326B1 (ja) |
KR (1) | KR100622879B1 (ja) |
CN (1) | CN1266134C (ja) |
AR (1) | AR038781A1 (ja) |
AT (1) | ATE396972T1 (ja) |
AU (1) | AU2002325493B2 (ja) |
CA (1) | CA2455298C (ja) |
DE (1) | DE60226878D1 (ja) |
ES (1) | ES2305278T3 (ja) |
HK (1) | HK1064673A1 (ja) |
MX (1) | MXPA04001171A (ja) |
MY (1) | MY129094A (ja) |
TW (1) | TWI221838B (ja) |
WO (1) | WO2003016279A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004082683A1 (ja) * | 2003-03-17 | 2004-09-30 | Kyowa Hakko Kogyo Co., Ltd. | 慢性皮膚疾患の治療および/または予防剤 |
WO2004087147A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co., Ltd. | 肺疾患の治療および/または予防剤 |
WO2004087148A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co. Ltd. | 肺疾患の治療および/または予防剤 |
WO2004096274A1 (ja) * | 2003-03-31 | 2004-11-11 | Kyowa Hakko Kogyo Co., Ltd. | 気道内投与剤 |
WO2005056009A1 (ja) * | 2003-12-12 | 2005-06-23 | Kyowa Hakko Kogyo Co., Ltd. | 肺疾患治療剤 |
WO2006046774A1 (en) * | 2004-10-29 | 2006-05-04 | Tanabe Seiyaku Co., Ltd. | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014128585A1 (en) | 2013-02-19 | 2014-08-28 | Pfizer Inc. | Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders |
WO2016012896A1 (en) | 2014-07-24 | 2016-01-28 | Pfizer Inc. | Pyrazolopyrimidine compounds |
EP3177624B1 (en) | 2014-08-06 | 2019-05-01 | Pfizer Inc | Imidazopyridazine compounds |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678501A (en) * | 1981-07-30 | 1987-07-07 | Union Carbide Corporation | Certain pyrazinyl 1,3 cycloalkanedione derivatives having herbicidal activity |
EP0557016A1 (en) * | 1992-02-20 | 1993-08-25 | Tanabe Seiyaku Co., Ltd. | Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor |
EP0748805A1 (en) * | 1995-06-15 | 1996-12-18 | Tanabe Seiyaku Co., Ltd. | Naphthalene derivatives, process for the preparation thereof, and intermediates therefor, and pharmaceutical compositions comprising them |
JP2000063275A (ja) * | 1998-06-12 | 2000-02-29 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
AU5305299A (en) * | 1998-08-26 | 2000-03-21 | Tanabe Seiyaku Co., Ltd. | Naphthyridine derivatives and process for the preparation thereof |
WO2002000657A2 (en) * | 2000-06-26 | 2002-01-03 | Lilly Icos Llc | Condensed pyrazindione derivatives |
WO2002038563A2 (en) * | 2000-11-08 | 2002-05-16 | Lilly Icos Llc | Condensed pyrazindione derivatives as pde inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728844A (en) | 1995-08-29 | 1998-03-17 | Celgene Corporation | Immunotherapeutic agents |
GB9603723D0 (en) | 1996-02-22 | 1996-04-24 | Merck & Co Inc | Diphenyl pyridyl derivatives as pde iv inhibitors |
DE19617864A1 (de) | 1996-04-23 | 1997-10-30 | Schering Ag | Neue chirale Phenyldihydrofuranone |
GB9614718D0 (en) | 1996-07-12 | 1996-09-04 | Bayer Ag | 3-ureido-pyridofurans and -pyridothiophenes |
BR9712005A (pt) | 1996-09-04 | 1999-08-24 | Pfizer | Derivados de indazol e seus usos como inibidores de fosfodiesterase (pde) tipo IV e produ-Æo do fator de necrose de tumor (tnf) |
PL194673B1 (pl) | 1996-10-02 | 2007-06-29 | Janssen Pharmaceutica Nv | Pochodna 2-cyjanoiminoimidazolu, sposób jej wytwarzania i zastosowanie oraz kompozycja farmaceutyczna |
MXPA03010672A (es) | 2001-05-23 | 2004-03-02 | Tanabe Seiyaku Co | Composicion para el tratamiento regenerativo de enfermedades del cartilago. |
CA2447619A1 (en) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | A composition for accelerating bone fracture healing |
-
2002
- 2002-07-30 TW TW091116963A patent/TWI221838B/zh not_active IP Right Cessation
- 2002-07-31 CN CNB028155378A patent/CN1266134C/zh not_active Expired - Fee Related
- 2002-07-31 AT AT02758780T patent/ATE396972T1/de not_active IP Right Cessation
- 2002-07-31 CA CA002455298A patent/CA2455298C/en not_active Expired - Fee Related
- 2002-07-31 ES ES02758780T patent/ES2305278T3/es not_active Expired - Lifetime
- 2002-07-31 US US10/486,088 patent/US7153859B2/en not_active Expired - Fee Related
- 2002-07-31 KR KR1020047002009A patent/KR100622879B1/ko not_active IP Right Cessation
- 2002-07-31 DE DE60226878T patent/DE60226878D1/de not_active Expired - Lifetime
- 2002-07-31 MX MXPA04001171A patent/MXPA04001171A/es active IP Right Grant
- 2002-07-31 WO PCT/JP2002/007783 patent/WO2003016279A1/ja active IP Right Grant
- 2002-07-31 AU AU2002325493A patent/AU2002325493B2/en not_active Ceased
- 2002-07-31 EP EP02758780A patent/EP1424326B1/en not_active Expired - Lifetime
- 2002-08-06 MY MYPI20022928A patent/MY129094A/en unknown
- 2002-08-08 AR ARP020103001A patent/AR038781A1/es not_active Application Discontinuation
-
2004
- 2004-10-05 HK HK04107642.3A patent/HK1064673A1/xx not_active IP Right Cessation
-
2006
- 2006-09-06 US US11/515,737 patent/US7550464B2/en not_active Expired - Fee Related
- 2006-09-06 US US11/515,907 patent/US7550475B2/en not_active Expired - Fee Related
- 2006-09-06 US US11/515,928 patent/US7550476B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678501A (en) * | 1981-07-30 | 1987-07-07 | Union Carbide Corporation | Certain pyrazinyl 1,3 cycloalkanedione derivatives having herbicidal activity |
EP0557016A1 (en) * | 1992-02-20 | 1993-08-25 | Tanabe Seiyaku Co., Ltd. | Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor |
EP0748805A1 (en) * | 1995-06-15 | 1996-12-18 | Tanabe Seiyaku Co., Ltd. | Naphthalene derivatives, process for the preparation thereof, and intermediates therefor, and pharmaceutical compositions comprising them |
JP2000063275A (ja) * | 1998-06-12 | 2000-02-29 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
AU5305299A (en) * | 1998-08-26 | 2000-03-21 | Tanabe Seiyaku Co., Ltd. | Naphthyridine derivatives and process for the preparation thereof |
WO2002000657A2 (en) * | 2000-06-26 | 2002-01-03 | Lilly Icos Llc | Condensed pyrazindione derivatives |
WO2002038563A2 (en) * | 2000-11-08 | 2002-05-16 | Lilly Icos Llc | Condensed pyrazindione derivatives as pde inhibitors |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004082683A1 (ja) * | 2003-03-17 | 2004-09-30 | Kyowa Hakko Kogyo Co., Ltd. | 慢性皮膚疾患の治療および/または予防剤 |
WO2004087147A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co., Ltd. | 肺疾患の治療および/または予防剤 |
WO2004087148A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co. Ltd. | 肺疾患の治療および/または予防剤 |
WO2004096274A1 (ja) * | 2003-03-31 | 2004-11-11 | Kyowa Hakko Kogyo Co., Ltd. | 気道内投与剤 |
WO2005056009A1 (ja) * | 2003-12-12 | 2005-06-23 | Kyowa Hakko Kogyo Co., Ltd. | 肺疾患治療剤 |
WO2006046774A1 (en) * | 2004-10-29 | 2006-05-04 | Tanabe Seiyaku Co., Ltd. | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
Also Published As
Publication number | Publication date |
---|---|
US20070004740A1 (en) | 2007-01-04 |
EP1424326A1 (en) | 2004-06-02 |
KR20040023742A (ko) | 2004-03-18 |
AU2002325493B2 (en) | 2005-06-09 |
CN1266134C (zh) | 2006-07-26 |
TWI221838B (en) | 2004-10-11 |
CN1538959A (zh) | 2004-10-20 |
US20040204418A1 (en) | 2004-10-14 |
EP1424326A4 (en) | 2005-08-17 |
US7550464B2 (en) | 2009-06-23 |
US20070010521A1 (en) | 2007-01-11 |
AR038781A1 (es) | 2005-01-26 |
US7153859B2 (en) | 2006-12-26 |
MXPA04001171A (es) | 2004-05-20 |
CA2455298C (en) | 2009-10-13 |
HK1064673A1 (en) | 2005-04-08 |
ATE396972T1 (de) | 2008-06-15 |
EP1424326B1 (en) | 2008-05-28 |
CA2455298A1 (en) | 2003-02-27 |
KR100622879B1 (ko) | 2006-09-14 |
US7550476B2 (en) | 2009-06-23 |
DE60226878D1 (de) | 2008-07-10 |
US20070004739A1 (en) | 2007-01-04 |
MY129094A (en) | 2007-03-30 |
ES2305278T3 (es) | 2008-11-01 |
US7550475B2 (en) | 2009-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2160444A1 (en) | Aroyl-piperdine derivatives | |
AU6520998A (en) | 1,4-substituted cyclic amine derivatives | |
AU2420897A (en) | Meta-substituted phenylene sulphonamide derivatives | |
AU2337097A (en) | Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors | |
MXPA04005350A (es) | Compuesto de dibencilamina, y uso medicinal del mismo. | |
WO2002000650A3 (en) | Novel compounds possessing antibacterial, antifungal or antitumor activity | |
PT870765E (pt) | Derivados de aminotiazole drogas contendo os mesmos e intermediarios na producao dos compostos | |
WO1998003505A3 (en) | Heterocyclic compounds, their production and use | |
EP1642880A4 (en) | PROTEIN INHIBITOR OF THE HSP90 FAMILY | |
CA2315050A1 (en) | Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof | |
WO1998035951A3 (en) | New aminopiperazine derivatives | |
WO1999000373A8 (fr) | Derives de benzimidazole | |
MY128323A (en) | Thiazole derivatives for inhibition of cytokine production and of cell adhesion | |
WO2003016279A1 (fr) | Composes polycycliques fusionnes | |
IL136100A (en) | Biphenylamidine derivatives and pharmaceutical compositions containing the same | |
HK1052697A1 (en) | Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same. | |
HK1048113A1 (en) | Novel compounds | |
CA2371827A1 (en) | Amide compounds for the potentiation of cholinergic activity | |
NO973213L (no) | Nye 2-(1H)-quinolinforbindelser, fremgangsmåter ved fremstilling av slike samt farmasöytiske sammensetninger omfattende disse | |
EP1535920A4 (en) | PROCESS FOR THE PREPARATION OF 1,3-BENZODIOXOLE-2-SPIRO-CYCLOALCAN DERIVATIVES | |
EP0335979A4 (en) | Thienopyrimidine derivatives | |
CA2112061A1 (en) | Alkyl substituted heterocyclic compounds | |
EP1241165A4 (en) | OPTICALLY ACTIVE CHROMANE AND THIOCHROMANE DERIVATIVES | |
AU6594900A (en) | Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents | |
WO2000064902A3 (en) | Process for the preparation of calanolide precursors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KR KZ LC LR LS LT LU LV MA MD MG MK MN MX MZ NO NZ OM PH PL PT RO RU SE SG SI SK SL TJ TM TN TR TT TZ UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002325493 Country of ref document: AU Ref document number: 2455298 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002758780 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10486088 Country of ref document: US Ref document number: PA/a/2004/001171 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028155378 Country of ref document: CN Ref document number: 1020047002009 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2002758780 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002325493 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002758780 Country of ref document: EP |